Will Mylan shareholders get Viatris stock?

Will Viatris be publicly traded?

The combined company was renamed Viatris in connection with the closing of the combination, and is now an independent, publicly traded company. Viatris trades on Nasdaq under the symbol “VTRS”.

Will Viatris have a dividend?

(VTRS) will begin trading ex-dividend on May 21, 2021. A cash dividend payment of $0.11 per share is scheduled to be paid on June 16, 2021. Shareholders who purchased VTRS prior to the ex-dividend date are eligible for the cash dividend payment. At the current stock price of $15.5, the dividend yield is 2.84%.

What is VTRS spinoff?

Pfizer recently completed a spin-off of it’s Upjohn business, combining it with Mylan N.V. to form a new entity, Viatris, which began trading on 11/16/2020 under the ticker symbol VTRS. Mylan N.V. was delisted from the Nasdaq stock exchange as a result of this corporate action and is no longer tradeable.

Why is Mylan stock so low?

Mylan Stock Is Falling Because the Upjohn Deal Won’t Soon Help Earnings, Analyst Says. One of the biggest questions for biopharma investors in 2020 is what to make of the big new generic-drug company being formed by the merger Mylan with Pfizer’s off-patent drug division.

IT IS INTERESTING:  Quick Answer: How much money would you have if you invested in Bitcoin in 2010?

Why did I get shares of Viatris?

That’s because Viatris was formed through the merger of Mylan and Upjohn, the generics unit of Pfizer (NYSE:PFE). Pfizer shareholders were given a little more than 12 shares in Viatris for every 100 they held in Pfizer. Mylan shareholders got a Viatris share for every previous Mylan share they held.

Is Viatris stock a buy or sell?

Viatris has received a consensus rating of Hold. The company’s average rating score is 2.21, and is based on 4 buy ratings, 9 hold ratings, and 1 sell rating.

Can I buy Viatris stock?

Viatris Inc., formerly Up Upjohn Inc., is a healthcare company. It is a scientific, manufacturing and distribution company that is specialized in delivering medicines to patients in over 165 countries and territories. , you can buy Viatris Inc stock in any dollar amount, or any other fund or stock you know on Stash.

Is VTRS stock a buy?

Out of 6 analysts, 0 (0%) are recommending VTRS as a Strong Buy, 1 (16.67%) are recommending VTRS as a Buy, 5 (83.33%) are recommending VTRS as a Hold, 0 (0%) are recommending VTRS as a Sell, and 0 (0%) are recommending VTRS as a Strong Sell.

Will VTRS pay a dividend in 2021?

(VTRS) will begin trading ex-dividend on August 23, 2021. A cash dividend payment of $0.11 per share is scheduled to be paid on September 16, 2021. Shareholders who purchased VTRS prior to the ex-dividend date are eligible for the cash dividend payment.

Does VTRS stock pay a dividend?

VTRS pays a dividend of $0.11 per share. VTRS’s annual dividend yield is 0.8%. Viatris’s dividend is lower than the US Drug Manufacturers – Specialty & Generic industry average of 2.03%, and it is lower than the US market average of 3.35%.

IT IS INTERESTING:  What is a dividend split rate?

Which stock has the highest dividend?

Dividend Aristocrat Companies With the Highest Dividends

Company Dividend yield
AT&T (T) 6.93%
T Rowe Price (TROW) 6.15%
ExxonMobil (XOM) 5.80%
Chevron (CVX) 5.05%

Is Viatris a good buy?

Valuation metrics show that Viatris Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of VTRS, demonstrate its potential to outperform the market.

Why do I have VTRS stock in my account?

If you see VTRS stock in your account, chances are that you owned Mylan shares. … Pfizer investors received 0.12 shares of Viatris for every one share of Pfizer held, which works out to 12 Viatris shares for every 100 Pfizer shares. Therefore, you may see VTRS stock in your account if you owned Pfizer shares.